Health ❯ Healthcare ❯ Cancer

Clinical Trials

Patient Outcomes Patient Enrollment Patient Support Services Patient Access mRNA Vaccines Brexit Impact Study Results Triple-Drug Therapy Patient Satisfaction Phase I Trials Stereotactic Body Radiotherapy Drug Development Adjuvant Therapy NHS England Initiatives Preclinical Models mRNA Vaccine At-Home Testing Research in Cancer Treatment Preclinical Studies STAMPEDE Trial Innovative Treatments Innovative Models UK Trials Public Perception Observational Studies TAILORx Study Risks and Benefits Patient Resources Immunotherapy Patient-Reported Outcomes Outcomes Pediatric Clinical Trials

AI Multimodal Model Outperforms Oncotype DX for Long-Term Breast Cancer Recurrence Risk

Trained on 4,462 TAILORx samples, the tool fuses pathology images with an expanded gene panel plus clinical variables.

EndRAD Phase 2 Finds Non-TBI Conditioning Matches Outcomes in MRD-Negative Young B-ALL

Global Consortium Publishes PRO Standards for Cancer Trials and Launches Implementation Toolkit

Lurie Children’s Launches Cal’s Angels Advanced Leukemia Program With $4 Million Gift

mRNA COVID Vaccination Linked to Longer Survival With Cancer Immunotherapy, Data Presented at ESMO

City of Hope Launches National Clinical Trial Network to Expand Access to Cancer Treatments

Decipher Prostate Test Identifies Docetaxel Benefit in Metastatic Prostate Cancer

NICE Approves Keytruda Combo for Advanced Endometrial Cancer on NHS

Nanoparticle Vaccine Clears Tumors in Over Half of Preclinical Pancreatic Cancer Models

Atezolizumab-Enhanced Chemotherapy Halves Recurrence in Stage III dMMR Colon Cancer